Analysis report on global and Chinese pharmaceutical excipients industry competition and marketing model 2022-2028

Analysis report on the competitive situation and marketing mode of the pharmaceutical excipients industry in the world and China 2022-2028 year
------------------------------------- 
《 Publisher 》： Hongsheng Xinhe Research Institute 【 Specialist Customer Service docking 】
《 Revision date 》：2022 year 2 month
《 Customer service 》： Wen Wen Zhou
【 For specific data analysis, please consult Hongsheng Xinhe Research Institute ！】 
Catalog
The first 1 Chapter ： Overview of pharmaceutical excipients industry in China
1.1 Industry research background and methods
1.1.1 Background of industry research
1.1.2 Methods of industry research
1.2 The concept of pharmaceutical excipients
1.2.1 Definition of pharmaceutical excipients
1.2.2 Characteristics of pharmaceutical excipients
1.3 Classification of pharmaceutical excipients
1.4 Business model of pharmaceutical excipients industry
1.5 Pharmaceutical excipients industry chain
1.5.1 Brief introduction to pharmaceutical excipients industry chain
1.5.2 Pharmaceutical excipients upstream industry analysis
（1） Basic chemical raw material manufacturing
（2） Agricultural and sideline food processing industry
（3） Food and feed additive manufacturing industry
1.5.3 Analysis of downstream industries of pharmaceutical excipients
（1） Chemical preparation industry
（2） Chinese patent medicine industry
（3） Biopharmaceutical industry
1.5.4 Interaction between preparation and pharmaceutical excipients
（1） The product structure of the preparation determines the level of pharmaceutical excipients
（2） The level of pharmaceutical excipients restricts the export of Chinese preparations
（3） The export of preparations is expected to stimulate the development of pharmaceutical excipients
The first 2 Chapter ： Analysis on the development environment of Chinese pharmaceutical excipients industry
2.1 Analysis on economic environment of pharmaceutical excipients industry
2.1.1 China GDP Growth analysis
2.1.2 Economic and environmental impact analysis
2.2 Analysis on industrial environment of pharmaceutical excipients industry
2.2.1 Analysis of the current situation of pharmaceutical industry development
（1） Analysis on the development of pharmaceutical manufacturing industry
1） Production and marketing scale of pharmaceutical manufacturing industry
2） The development prospect of pharmaceutical manufacturing industry
（2） Analysis of pharmaceutical business development
1） The scale of pharmaceutical commercial market
2） The prospect of pharmaceutical commercial market
（3） Development status of medical service industry
1） The size of the medical service market
2） The development prospect of medical service industry
2.2.2 Industrial environmental impact analysis
2.3 Analysis on policy environment of pharmaceutical excipients industry
2.3.1 Industry authorities
2.3.2 Industry supervision system
2.3.3 Industry related policies
2.4 Analysis on social environment of pharmaceutical excipients industry
2.4.1 The safety of pharmaceutical excipients
2.4.2 Environmental protection problems in pharmaceutical excipients industry
2.5 Analysis on technical environment of pharmaceutical excipients industry
2.5.1 Industry technology activity analysis
2.5.2 Quality analysis of industrial patent output
2.5.3 Composition of industrial patent applicants
The first 3 Chapter ： Overview of international pharmaceutical excipients industry and its reference significance
3.1 General situation of the development of international pharmaceutical excipients industry
3.1.1 Development of international pharmaceutical excipients industry
（1） Development status of international pharmaceutical excipients industry
1） The industry is basically mature
2） Industry supervision is gradually improved
3） Industry standards are gradually improving
（2） The development trend of international new pharmaceutical excipients
3.1.2 Market scale of international pharmaceutical excipients industry
3.1.3 Product structure of international pharmaceutical excipients industry
（1） Organic pharmaceutical excipients
（2） Inorganic pharmaceutical excipients
（3） accord with USP Water for medicine
3.1.4 The competitive situation of international pharmaceutical excipients industry
（1） Major manufacturers in the international pharmaceutical excipients industry
（2） Analysis on investment merger and reorganization of international pharmaceutical excipients industry
1） Analysis on the motivation of investment merger and reorganization of international pharmaceutical excipients industry
2） Analysis on the investment merger and reorganization of international pharmaceutical excipients industry
3.1.5 International pharmaceutical excipients Association （IPEC） survey
3.2 Analysis of pharmaceutical excipients industry in major countries
3.2.1 Regional distribution of international pharmaceutical excipients
3.2.2 Analysis of pharmaceutical excipients industry in the United States
（1） Definition and classification of auxiliary materials
1） Definition of excipients
2） Classification of auxiliary materials
（2） Management of new auxiliary materials
1） Definition of new excipients
2） Application requirements for new auxiliary materials
3） Non clinical safety evaluation
4）DMF IV
（3） Management of auxiliary material production
（4） Management of auxiliary material operation
（5） Management of auxiliary material use
（6） The impact of the new pharmacopoeia
（7）FDA Auxiliary material spectrum library
3.2.3 EU pharmaceutical excipients industry analysis
（1） Definition and classification of auxiliary materials
1） Definition of excipients
2） Classification of auxiliary materials
（2） Approval of new auxiliary materials
1） Definition of new excipients
2） Approval requirements for new auxiliary materials
（3） Management of auxiliary material production
（4） Management of auxiliary material operation
（5） Management of auxiliary material use
1） Relevant requirements in drug application
2） Relevant requirements in the drug instructions
3.2.4 Analysis of pharmaceutical excipients industry in Japan
（1） Definition of excipients
1） Definition of excipients
2） Definition of new excipients
（2） Management of auxiliary materials
1） Production of auxiliary materials
2） Management of new auxiliary materials
（3） Standard of auxiliary materials
3.2.5 Comparison of management of pharmaceutical excipients in different countries
（1） Supervision of pharmaceutical excipients
1） International pharmaceutical excipients supervision
2） Domestic pharmaceutical excipients supervision
（2） Definition and classification of auxiliary materials
1） The definition of excipients is quite
2） Classification and comparison of auxiliary materials
（3） Management of new auxiliary materials
1） The definition of new excipients is more
2） Approval comparison of new auxiliary materials
（4） Comparison of auxiliary material production management
（5） Comparison of auxiliary material management
（6） Comparison of auxiliary material use management
1） The problems in our country
2） Foreign models
3.3 Comparative analysis on the differences of pharmaceutical excipients at home and abroad
3.3.1 The difference in kind and frequency of use
3.3.2 Differences in quality standards
3.3.3 Differences in detection methods
3.3.4 Differences in scientific research and development
（1） Research and development status of new auxiliary materials abroad
1） The research and development focus of foreign new auxiliary materials
2） Research and development characteristics of foreign new auxiliary materials
（2） Research and development of new auxiliary materials in China
1） Research and development focus of domestic new auxiliary materials
2） Research and development characteristics of new domestic auxiliary materials
3.3.5 Differences in applied research
3.3.6 Differences in production and operation
3.4 Analysis of international leading pharmaceutical excipients enterprises
3.4.1 Rogate （Roquette）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprises invest in China
3.4.2 Dow chemistry （DOW）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprise operation
（4） Enterprises invest in China
3.4.3 BASF （BASF）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprise operation
（4） Enterprises invest in China
3.4.4 American international specialty （ISP）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprises invest in China
3.4.5 Degussa （Degussa）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） The operation of the company
（4） Enterprises invest in China
3.4.6 Jiafasai （Gattefossé）
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprises invest in China
3.4.7 Germany JRS The group
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprises invest in China
3.4.8 Asahi Kasei Co., Ltd
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprise operation
（4） Enterprises invest in China
3.4.9 New Zealand lactose
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
3.4.10 Hercules
（1） Overview of enterprise development
（2） Enterprise auxiliary material business
（3） Enterprises invest in China
The first 4 Chapter ： Analysis on development and competition of pharmaceutical excipients industry in China
4.1 General situation of the development of Chinese pharmaceutical excipients industry
4.1.1 The development history of Chinese pharmaceutical excipients industry
4.1.2 Development status of pharmaceutical excipients industry in China
4.2 There are problems in the development of Chinese pharmaceutical excipients industry
4.2.1 The standard system of pharmaceutical excipients is not perfect
4.2.2 The management system of pharmaceutical excipients is not perfect
4.2.3 The industrial structure of pharmaceutical excipients is unreasonable
4.2.4 Pharmaceutical excipients differ greatly from the same product
4.3 Analysis on the development scale of Chinese pharmaceutical excipients industry
4.3.1 According to the proportion of total industrial output value
4.3.2 Calculated according to the total output value of bulk products
4.3.3 Calculated according to the sales volume of auxiliary material enterprises
4.4 Competition analysis of Chinese pharmaceutical excipients industry
4.4.1 Analysis of production enterprise pattern
4.4.2 Market share analysis
（1） Market share of foreign enterprises
（2） Market share of domestic enterprises
4.5 Porter's five forces analysis of Chinese pharmaceutical excipients industry
4.5.1 Analysis on the current situation of industry competition
4.5.2 Threat analysis of new entrants
4.5.3 Threat analysis of alternatives
4.5.4 Upstream bargaining power analysis
4.5.5 Downstream bargaining power analysis
4.5.6 Competition summary
4.6 Analysis on the competitive strategy of Chinese pharmaceutical excipients industry
4.6.1 Cost strategy analysis
（1） Applicable conditions for cost strategy of pharmaceutical excipients industry
（2） Cost strategy implementation case of pharmaceutical excipients industry
4.6.2 Differentiation strategy analysis
（1） Applicable conditions for differentiation strategy of pharmaceutical excipients industry
（2） Implementation case of differentiation strategy in pharmaceutical excipients industry
4.6.3 Centralized strategy analysis
（1） Applicable conditions for the centralization strategy of pharmaceutical excipients industry
（2） The implementation case of centralization strategy in pharmaceutical excipients industry
The first 5 Chapter ： Analysis on the development model of Chinese pharmaceutical excipients industry
5.1 Analysis on the business model of Chinese pharmaceutical excipients industry
5.1.1 “ production + sales ” Business model
5.1.2 “ production + OEM ” Business model
5.1.3 “ Research and development + manufacturing + sales ” Business model
5.1.4 “ production + service ” Business model
5.2 Analysis on the marketing model of Chinese pharmaceutical excipients industry
5.2.1 Analysis of the current marketing model of Chinese pharmaceutical excipients industry
（1） Direct selling model
（2） Consignment mode
（3） Pattern contrast
5.2.2 Analysis on the emerging marketing model of Chinese pharmaceutical excipients industry
5.3 Brand strategy analysis of Chinese pharmaceutical excipients industry
5.3.1 Analysis on the necessity of brand building in pharmaceutical auxiliary industry
（1） The needs of the enterprise itself
（2） Cater to customers' needs
（3） The needs of industry competition
（4） The need of international marketing
5.3.2 Strategic analysis of pharmaceutical excipients from regional brands to national brands
（1） Analysis of regional brand phenomenon in pharmaceutical excipients industry
（2） Analysis on regional brand positioning of pharmaceutical excipients industry
（3） Analysis on the advantages and disadvantages of regional brands in pharmaceutical excipients industry
（4） Analysis on the breakthrough point of regional brand expansion to the whole country in the pharmaceutical accessories industry
1） Management breakthrough
2） Talent breakthrough
3） Capital breakthrough
4） Market breakthrough
5） Communication breakthrough
5.3.3 Suggestions on brand development of pharmaceutical excipients industry
（1） Market upgrade
（2） Brand upgrading
The first 6 Chapter ： Market analysis of pharmaceutical excipients in China
6.1 Market overview of pharmaceutical excipients
6.2 Market analysis of solid preparation excipients
6.2.1 Market analysis of medicinal sucrose
（1） Analysis on the application range of medicinal sucrose
（2） Analysis on the market scale of medicinal sucrose
（3） Market competition analysis of medicinal sucrose
6.2.2 Pharmaceutical starch Market Analysis
（1） Analysis of the application range of medicinal starch
（2） Analysis on the market scale of medicinal starch
（3） Market competition analysis of medicinal starch
6.2.3 Analysis of pharmaceutical cyclodextrin market
（1） Analysis of the application range of medicinal cyclodextrin
（2） International market analysis of pharmaceutical cyclodextrin
（3） Analysis on the market scale of pharmaceutical cyclodextrin
（4） Market competition analysis of pharmaceutical cyclodextrin
（5） Analysis of import and export of pharmaceutical cyclodextrins
6.2.4 Pharmaceutical lactose market analysis
（1） Analysis of the application range of medicinal lactose
（2） Pharmacopoeia standard for pharmaceutical lactose, new edition
（3） Market competition analysis of pharmaceutical lactose
6.2.5 Market analysis of medicinal mannitol
（1） Analysis of the application range of mannitol for medicinal use
（2） Analysis on the market scale of medicinal mannitol
（3） Analysis on the market competition of medicinal mannitol
6.2.6 Pharmaceutical gelatin Market Analysis
（1） Analysis of the application range of medicinal gelatin
（2） Analysis of new sources of medicinal gelatin
（3） International market analysis of medicinal gelatin
（4） Analysis on the market scale of pharmaceutical gelatin
（5） Market competition analysis of medicinal gelatin
6.2.7 Market analysis of medicinal hollow capsules
（1） Analysis on the market scale of medicinal hollow capsules
（2） Analysis on the market competition of medicinal hollow capsules
（3） Analysis on the market prospect of medicinal hollow capsules
（4） Analysis of market scale of non gelatin medicinal hollow capsules
（5） Analysis on the market competition of non gelatin medicinal hollow capsules
（6） Analysis on the market prospect of non gelatin medicinal hollow capsules
6.3 Market analysis of liquid excipients
6.3.1 Market analysis of medicinal beet red
（1） Analysis on the application range of medicinal beet red
（2） International market analysis of medicinal beet red
（3） Analysis on the market scale of medicinal beet red
（4） Yield analysis of medicinal beet red
（5） Market competition analysis of medicinal beet red
6.3.2 Market analysis of medicinal Stevia
（1） Analysis of the application range of Stevia for medicinal use
（2） International market analysis of medicinal Stevia
（3） Yield analysis of medicinal Stevia
（4） Market competition analysis of medicinal Stevia
（5） Analysis on the import and export of Stevia for medicinal purposes
6.3.3 Market analysis of medicinal saccharin sodium
（1） Analysis of the application range of medicinal saccharin sodium
（2） Market price analysis of medicinal saccharin sodium
（3） Market scale analysis of medicinal saccharin sodium
（4） Analysis of import and export of medicinal saccharin sodium
6.3.4 Market analysis of medicinal aspartame
（1） Analysis of the application range of aspartame for medicinal use
（2） Market price analysis of aspartame
（3） International market analysis of aspartame for medicinal use
（4） Analysis on the domestic market of aspartame for medicinal use
6.3.5 Market analysis of pharmaceutical high fructose syrup
（1） Analysis of the application range of medicinal high fructose syrup
（2） Analysis on the international market of medicinal high fructose syrup
（3） Analysis on the domestic market of medicinal high fructose syrup
6.3.6 Market analysis of medicinal xylitol
（1） Analysis of the application range of medicinal xylitol
（2） The development history of the medical xylitol industry
（3） Analysis on the market scale of medicinal xylitol
（4） Analysis on the market competition of medicinal xylitol
（5） Analysis on the development prospect of medicinal xylitol
6.3.7 Market analysis of medical maltitol
（1） Analysis on the application range of medical maltitol
（2） Development history of medical maltitol industry
（3） Analysis on the market scale of medical maltitol
（4） Analysis on the market competition of medical maltitol
（5） Analysis on the development prospect of medical maltitol
6.3.8 Market analysis of medicinal sorbitol
（1） Analysis of the application range of medicinal sorbitol
（2） Development history of pharmaceutical sorbitol industry
（3） Analysis on the market scale of medicinal sorbitol
（4） Market competition analysis of medicinal sorbitol
6.3.9 Market analysis of pharmaceutical hyaluronic acid
（1） Analysis of the application range of pharmaceutical hyaluronic acid
（2） International market analysis of pharmaceutical hyaluronic acid
（3） Analysis of domestic market of pharmaceutical hyaluronic acid
6.4 Market analysis of new pharmaceutical excipients
6.4.1 Excipients for slow and controlled release preparations
（1） Overview of excipients for sustained and controlled release preparations
（2） Application of excipients in slow and controlled release preparations
（3） Medicinal microcrystalline cellulose （MCC） Market analysis
1） Medicinal microcrystalline cellulose （MCC） Application range analysis
2） Medicinal microcrystalline cellulose （MCC） Market size analysis
3） Medicinal microcrystalline cellulose （MCC） Market competition analysis
（4） Medical polyvinylpyrrolidone （PVP） Market analysis
1） Medical polyvinylpyrrolidone （PVP） Application range analysis
2） Medical polyvinylpyrrolidone （PVP） Market size analysis
3） Medical polyvinylpyrrolidone （PVP） Market competition analysis
6.4.2 Microencapsulation and balling
（1） Classification of microencapsulation and microencapsulation excipients
（2） Application of micro encapsulation and micro balling excipients
（3） Market analysis of medicinal chitosan
1） Analysis of the application range of medicinal chitosan
2） International market analysis of medicinal chitosan
3） Domestic market analysis of medicinal chitosan
4） Analysis on the industrialization of medicinal chitosan
（4） Market analysis of medicinal seaweed polysaccharide
1） Pharmaceutical agar market analysis
2） Pharmaceutical carrageenan market analysis
3） Market analysis of medical alginate
4） The development prospect of medicinal seaweed polysaccharides
6.4.3 Premixed excipients
（1） Definition of premixed excipients
（2） Industrialization Analysis of premixed auxiliary materials
（3） Industry development trend
6.4.4 Nano excipients
（1） Definition of nano excipients
（2） Application of nano excipients
（3） Industry development trend
6.4.5 New excipients for traditional Chinese medicine preparations
（1） The application of new excipients in the formulation of traditional Chinese medicine
1） capsule
2） Sustained and controlled release preparations
3） Dispersible tablets
4） Cataplasm
5） Transdermal absorbent
6） Microspheres and liposomes
（2） Application of bioavailability of new excipients
1） Phospholipid complex
2） Self microemulsion system
The first 7 Chapter ： Analysis on key regions of pharmaceutical excipients industry in China
7.1 Development analysis and forecast of pharmaceutical excipients industry in Shandong Province
7.1.1 The development situation and characteristics of pharmaceutical excipients industry in Shandong Province
（1） The position of Shandong Pharmaceutical Excipients industry in the country
（2） The main manufacturers of pharmaceutical excipients in Shandong Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Shandong Province
（4） Shandong Pharmaceutical Excipients industry features
7.1.2 Analysis on downstream demand of pharmaceutical excipients industry in Shandong Province
（1） Shandong chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Shandong Province
（3） Shandong biopharmaceutical industry
7.1.3 Prediction on the development prospect of pharmaceutical excipients industry in Shandong Province
7.2 Development analysis and forecast of pharmaceutical excipients industry in Jiangsu Province
7.2.1 The development and characteristics of pharmaceutical excipients industry in Jiangsu Province
（1） The position of pharmaceutical excipients industry in Jiangsu Province in the country
（2） Main manufacturers of pharmaceutical excipients in Jiangsu Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Jiangsu Province
（4） Characteristics of pharmaceutical excipients industry in Jiangsu Province
7.2.2 Analysis on downstream demand of pharmaceutical excipients industry in Jiangsu Province
（1） Jiangsu chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Jiangsu Province
（3） Jiangsu biopharmaceutical industry
7.2.3 Prediction on the development prospect of pharmaceutical excipients industry in Jiangsu Province
7.3 Analysis and forecast on the development of pharmaceutical excipients industry in Zhejiang Province
7.3.1 General situation and characteristics of pharmaceutical excipients industry in Zhejiang Province
（1） The position of pharmaceutical excipients industry in Zhejiang Province in the country
（2） Major manufacturers of pharmaceutical excipients in Zhejiang Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Zhejiang Province
（4） The characteristics of pharmaceutical excipients industry in Zhejiang Province
7.3.2 Analysis on downstream demand of pharmaceutical excipients industry in Zhejiang Province
（1） Zhejiang chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Zhejiang Province
（3） Zhejiang biopharmaceutical industry
7.3.3 Prediction on the development prospect of pharmaceutical excipients industry in Zhejiang Province
7.4 Development analysis and forecast of pharmaceutical excipients industry in Shanghai
7.4.1 Development and characteristics of pharmaceutical excipients industry in Shanghai
（1） The position of Shanghai Pharmaceutical Excipients industry in the country
（2） The main manufacturers of pharmaceutical excipients in Shanghai
（3） Shanghai Pharmaceutical Excipients industry features
7.4.2 Analysis on downstream demand of pharmaceutical excipients industry in Shanghai
（1） Shanghai chemical pharmaceutical preparation industry
（2） Shanghai Chinese patent medicine industry
（3） Shanghai biopharmaceutical industry
7.4.3 Prediction on the development prospect of pharmaceutical excipients industry in Shanghai
7.5 Development analysis and forecast of pharmaceutical excipients industry in Jiangxi Province
7.5.1 General situation and characteristics of pharmaceutical excipients industry in Jiangxi Province
（1） The position of pharmaceutical excipients industry in Jiangxi Province in the country
（2） Main manufacturers of pharmaceutical excipients in Jiangxi Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Jiangxi Province
（4） Characteristics of pharmaceutical excipients industry in Jiangxi Province
7.5.2 Analysis on downstream demand of pharmaceutical excipients industry in Jiangxi Province
（1） Jiangxi chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Jiangxi Province
（3） Jiangxi biopharmaceutical industry
7.5.3 Prediction of the development prospect of pharmaceutical excipients industry in Jiangxi Province
7.6 Development analysis and forecast of pharmaceutical excipients industry in Anhui Province
7.6.1 The development situation and characteristics of the pharmaceutical excipients industry in Anhui Province
（1） The position of Anhui pharmaceutical excipients industry in the country
（2） Major manufacturers of pharmaceutical excipients in Anhui Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Anhui Province
（4） Anhui pharmaceutical excipients industry features
7.6.2 Analysis on downstream demand of pharmaceutical excipients industry in Anhui Province
（1） Anhui chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Anhui Province
（3） Anhui biopharmaceutical industry
7.6.3 Prediction of the development prospect of the pharmaceutical excipients industry in Anhui Province
7.7 Development analysis and forecast of pharmaceutical excipients industry in Guangdong Province
7.7.1 Development and characteristics of pharmaceutical excipients industry in Guangdong Province
（1） The position of the pharmaceutical excipients industry in Guangdong Province in the country
（2） Main manufacturers of pharmaceutical excipients in Guangdong Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Guangdong Province
（4） Characteristics of Guangdong pharmaceutical excipients industry
7.7.2 Analysis on downstream demand of pharmaceutical excipients industry in Guangdong Province
（1） Guangdong chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Guangdong Province
（3） Guangdong biopharmaceutical industry
7.7.3 Development prospect forecast of pharmaceutical excipients industry in Guangdong Province
7.8 Analysis and forecast on the development of pharmaceutical excipients industry in Henan Province
7.8.1 The development situation and characteristics of pharmaceutical excipients industry in Henan Province
（1） The position of the pharmaceutical excipients industry in Henan Province in the country
（2） Main manufacturers of pharmaceutical excipients in Henan Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Henan Province
（4） Henan pharmaceutical excipients industry features
7.8.2 Analysis on downstream demand of pharmaceutical excipients industry in Henan Province
（1） Henan chemical preparation industry
（2） Chinese patent medicine industry in Henan Province
（3） Henan biopharmaceutical industry
7.8.3 Prospect forecast of pharmaceutical excipients industry in Henan Province
7.9 Development analysis and forecast of pharmaceutical excipients industry in Hubei Province
7.9.1 The development situation and characteristics of Hubei pharmaceutical excipients industry
（1） The position of Hubei pharmaceutical excipients industry in the country
（2） The main manufacturers of pharmaceutical excipients in Hubei Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Hubei Province
（4） Hubei pharmaceutical excipients industry features
7.9.2 Analysis on downstream demand of pharmaceutical excipients industry in Hubei Province
（1） Chemical preparations industry in Hubei Province
（2） Chinese patent medicine industry in Hubei Province
（3） Hubei biopharmaceutical industry
7.9.3 Prediction on the development prospect of pharmaceutical excipients industry in Hubei Province
7.10 Development analysis and forecast of pharmaceutical excipients industry in Hunan Province
7.10.1 The development situation and characteristics of pharmaceutical excipients industry in Hunan Province
（1） The position of pharmaceutical excipients industry in Hunan Province in the country
（2） Main manufacturers of pharmaceutical excipients in Hunan Province
（3） Industrial belt distribution of pharmaceutical excipients industry in Hunan Province
（4） Characteristics of pharmaceutical excipients industry in Hunan Province
7.10.2 Analysis on downstream demand of pharmaceutical excipients industry in Hunan Province
（1） Hunan chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Hunan Province
（3） Hunan biopharmaceutical industry
7.10.3 Prediction on the development prospect of pharmaceutical excipients industry in Hunan Province
7.11 Analysis and forecast of the development of pharmaceutical excipients industry in Hebei Province
7.11.1 General situation and characteristics of the development of pharmaceutical excipients industry in Hebei Province
（1） The position of Hebei Pharmaceutical Excipients industry in the country
（2） Main manufacturers of pharmaceutical excipients in Hebei Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Hebei Province
（4） Hebei Pharmaceutical Excipients industry features
7.11.2 Analysis on downstream demand of pharmaceutical excipients industry in Hebei Province
（1） Hebei Chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Hebei Province
（3） Biopharmaceutical industry in Hebei Province
7.11.3 Prediction of the development prospect of the pharmaceutical excipients industry in Hebei Province
7.12 Analysis and forecast on the development of pharmaceutical excipients industry in Beijing
7.12.1 Development and characteristics of Beijing pharmaceutical excipients industry
（1） The position of Beijing pharmaceutical excipients industry in the country
（2） Major manufacturers of pharmaceutical excipients in Beijing
（3） Beijing pharmaceutical excipients industry features
7.12.2 Analysis on downstream demand of pharmaceutical excipients industry in Beijing
（1） Beijing chemical pharmaceutical preparation industry
（2） Beijing proprietary Chinese medicine industry
（3） Beijing biopharmaceutical industry
7.12.3 Prediction of the development prospect of Beijing pharmaceutical excipients industry
7.13 Analysis and forecast on the development of pharmaceutical excipients industry in Tianjin
7.13.1 Development and characteristics of Tianjin Pharmaceutical Excipients industry
（1） The position of Tianjin Pharmaceutical Excipients industry in the country
（2） Tianjin is a major manufacturer of pharmaceutical excipients
（3） Tianjin Pharmaceutical Excipients industry features
7.13.2 Analysis on downstream demand of pharmaceutical excipients industry in Tianjin
（1） Tianjin Chemical pharmaceutical preparation industry
（2） Tianjin Chinese patent medicine industry
（3） Tianjin biopharmaceutical industry
7.13.3 Prediction of the development prospect of Tianjin Pharmaceutical Excipients industry
7.14 Development analysis and forecast of pharmaceutical excipients industry in Sichuan Province
7.14.1 Development and characteristics of Sichuan Pharmaceutical Excipients industry
（1） The position of Sichuan Pharmaceutical Excipients industry in the country
（2） Major manufacturers of pharmaceutical excipients in Sichuan Province
（3） Distribution of industrial belts of pharmaceutical excipients industry in Sichuan Province
（4） Characteristics of Sichuan Pharmaceutical Excipients industry
7.14.2 Analysis on downstream demand of pharmaceutical excipients industry in Sichuan Province
（1） Sichuan Chemical pharmaceutical preparation industry
（2） Chinese patent medicine industry in Sichuan Province
（3） Sichuan biopharmaceutical industry
7.14.3 Prediction of the development prospect of the pharmaceutical excipients industry in Sichuan Province
The first 8 Chapter ： Competition analysis of leading enterprises in Chinese pharmaceutical excipients industry
8.1 Analysis on the overall situation of Chinese pharmaceutical excipients enterprises
8.1.1 Fierce market competition
8.1.2 The market is in disorder
8.1.3 Insufficient R & D investment
8.1.4 Product homogeneity is serious
8.2 Analysis of leading pharmaceutical excipients enterprises in China
8.2.1 Analysis on the operation of Hunan Erkang Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of main financial indicators
（3） Enterprise profitability analysis
（4） Enterprise operation capability analysis
（5） An analysis of the solvency of an enterprise
（6） Analysis of enterprise development ability
（7） Enterprise product structure and new product trend
（8） Analysis on the advantages and disadvantages of enterprise operation
（9） Analysis of enterprise investment, merger and reorganization
（10） Analysis of the latest development trend of the enterprise
8.2.2 Analysis on the operation of Qinghai gelatin Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of main financial indicators
（3） Enterprise profitability analysis
（4） An analysis of the solvency of an enterprise
（5） Enterprise operation capability analysis
（6） Analysis of enterprise development ability
（7） Enterprise product structure and new product trend
（8） Enterprise sales channels and networks
（9） Analysis on the advantages and disadvantages of enterprise operation
（10） Analysis of enterprise investment, merger and reorganization
（11） Analysis of the latest development trend of the enterprise
8.2.3 Analysis on the operation of Anhui Shanhe pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
（6） Analysis of enterprise investment, merger and reorganization
（7） Analysis of the latest development trend of the enterprise
8.2.4 Analysis of the operation of Huzhou prospect Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.5 Analysis of the operation of Shandong Liaocheng Ahua Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
（6） Analysis of the latest development trend of the enterprise
8.2.6 Analysis of the operation of Tianjin aileyi pharmaceutical materials Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.7 Business analysis of Shanghai kalekang Coating Technology Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.8 Analysis of the operation of Beijing Yingmao Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.9 Analysis of the operation of Wenzhou Xiaolun Coating Technology Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.10 Analysis of the operation of Shandong Liaocheng Luxi pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.11 Analysis of the operation of Taian Ruitai cellulose Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.12 Analysis on the operation of Qufu Tianli pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
（5） Analysis of the latest development trend of the enterprise
8.2.13 Analysis of the operation of Jining Liujia pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.14 Analysis on the operation of Lianyungang Wantai pharmaceutical materials Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
（6） Analysis of the latest development trend of the enterprise
8.2.15 Analysis on the operation of Wujiang bachhe pharmaceutical auxiliary material factory
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.16 Analysis on the operation of Gaoyou Rixing pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Enterprise product structure and new product trend
（3） Enterprise sales channels and networks
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.17 Analysis of the operation of Shanghai Huamao Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.18 Analysis of the operation of Shanghai Puli membrane preparation Accessories Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.19 Analysis of the operation of Anhui Huangshan capsule Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
（6） Analysis of the latest development trend of the enterprise
8.2.20 Analysis of the operation of Puyang Hualu pharmaceutical excipients Co., Ltd
（1） Enterprise development profile analysis
（2） Enterprise product structure and new product trend
（3） Enterprise sales channels and networks
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.21 Analysis of the operation of Suzhou capsule Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
（5） Analysis of enterprise investment, merger and reorganization
8.2.22 Analysis on the operation of Jiangxi yipusheng Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Enterprise product structure and new product trend
（3） Enterprise sales channels and networks
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.23 Analysis of the operation of Weifang Shengtai Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Enterprise sales channels and networks
（5） Analysis on the advantages and disadvantages of enterprise operation
8.2.24 Analysis of the operation of Guangdong Zhaoqing Yuandong Pharmaceutical Excipients Factory Co., Ltd
（1） Enterprise development profile analysis
（2） Analysis of enterprise operation
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
8.2.25 Analysis of the operation of Hunan Huari Pharmaceutical Co., Ltd
（1） Enterprise development profile analysis
（2） Enterprise production technology and equipment analysis
（3） Enterprise product structure and new product trend
（4） Analysis on the advantages and disadvantages of enterprise operation
The first 9 Chapter ： Development prospects and investment suggestions of Chinese pharmaceutical excipients industry
9.1 Analysis on the development prospect of Chinese pharmaceutical excipients industry
9.1.1 Analysis on the influencing factors of the development of pharmaceutical excipients industry in China
（1） Analysis of the influence of policy factors
（2） Demand factors
（3） Technology drives
9.1.2 Analysis on the development trend of Chinese pharmaceutical excipients industry
（1） Industry development direction
（2） Industry development trend
9.2 Investment risks and suggestions of Chinese pharmaceutical excipients industry
9.2.1 Analysis of barriers to entry of pharmaceutical excipients industry
（1） Policy barriers
（2） Capital barriers
（3） technology barrier
9.2.2 Investment risk analysis of pharmaceutical excipients industry
（1） Industry policy risk
（2） Industry regulatory risk
（3） Market competition risk
（4） Related industry risks
9.2.3 Investment opportunities and suggestions for pharmaceutical excipients industry
（1） The investment prospect of pharmaceutical excipients industry
（2） Key customers in pharmaceutical excipients industry
（3） Research direction of pharmaceutical excipients industry
（4） Suggestions on investment in pharmaceutical excipients industry
Table of figures
Chart 1： Common industry research methods
Chart 2： Pharmaceutical excipients and APIs （ Pharmaceutical active ingredients ） The difference between
Chart 3： Classification of pharmaceutical excipients
Chart 4： Analysis of business model and participant characteristics of pharmaceutical excipients industry
Chart 5： Pharmaceutical excipients industry chain
Chart 6：2014-2021 Output value and growth rate of basic chemical raw material manufacturing industry in （ Company ： One hundred million yuan ,%）
Chart 7：2011-2021 Correlation analysis between the market scale of pharmaceutical excipients in China and the total output value of basic chemical raw materials in （ Company ： One hundred million yuan ）
Chart 8：2014-2021 Producer price index of domestic chemical raw materials and chemical products manufacturing in
Chart 9：2014-2021 Output value and growth rate of agricultural and non-staple food processing industry in （ Company ： One hundred million yuan ,%）
Chart 10：2011-2021 Analysis chart of the correlation between the size of China's pharmaceutical excipients market and the total output value of agricultural and sideline food processing industry in （ Company ： One hundred million yuan ）
Chart 11： In recent years, the producer price index of domestic agricultural and sideline food processing industry
Chart 12： The distribution of export sources of China's food additive industry
Chart 13：2014-2021 The total output value and sales revenue of the chemical preparation manufacturing industry in （ Company ： One hundred million yuan ,%）
Chart 14：2014-2021 The number of chemical pharmaceutical manufacturing enterprises in China in （ Company ： home ）
Chart 15：2011-2021 Analysis chart of the correlation between the size of China's pharmaceutical excipients market and the total output value of chemical preparations in （ Company ： One hundred million yuan ）
Chart 16：2014-2021 Total industrial output value and sales revenue of Chinese patent medicine industry in （ Company ： One hundred million yuan ,%）
Chart 17：2014-2021 Number of Chinese patent medicine enterprises in （ Company ： home ）
Chart 18：2011-2021 Analysis chart of the correlation between the size of China's pharmaceutical excipients market and the total output value of the Chinese patent medicine industry in （ Company ： One hundred million yuan ）
Chart 19：2014-2021 Total output value and sales revenue of biopharmaceutical industry in （ Company ： One hundred million yuan ,%）
Chart 20：2014-2021 The number of enterprises in China's biopharmaceutical industry in （ Company ： home ）
Chart 21：2011-2021 Analysis chart of the correlation between the size of China's pharmaceutical excipients market and the total output value of the biopharmaceutical industry in （ Company ： One hundred million yuan ）
Chart 22： The global consumption of pharmaceutical excipients by Region （ By weight ）（ Company ：%）
Chart 23： Varieties of commonly used auxiliary materials in different regions and existing quality standards
Chart 24： Comparison of output value ratio of auxiliary materials between China and other regions （ Company ：%）
Chart 25：2011-2021 Proportion of output value of pharmaceutical excipients in China's pharmaceutical industry in （ Company ：%）
Chart 26：2013-2021 China's GDP and its growth in （ Company ： Trillion yuan ,%）
Chart 27：2011-2021 China's pharmaceutical excipients market scale and GDP Correlation analysis diagram （ Company ： Trillion yuan , One hundred million yuan ）
Chart 28：2014-2021 Trend of total industrial output value and growth rate of pharmaceutical industry in （ Company ： One hundred million yuan ,%）
Chart 29：2014-2021 Trend chart of sales revenue and growth rate of pharmaceutical industry in （ Company ： One hundred million yuan ,%）
Chart 30：2022-2028 The growth forecast of the total industrial output value of China's pharmaceutical industry in （ Company ： One hundred million yuan ）
Chart 31：2011-2021 The scale and growth rate of the pharmaceutical commercial market in （ Company ： One hundred million yuan ,%）
Chart 32：2022-2028 Scale and forecast of pharmaceutical commercial market in （ Company ： One hundred million yuan ）
Chart 33：2008-2021 Statistics on the number of medical institutions in China in （ Company ： home ,%）
Chart 34：2009-2021 The number of people diagnosed and treated by Chinese medical institutions in （ Company ： Million people ,%）
Chart 35： Regulations related to the supervision of pharmaceutical excipients industry
Chart 36： Analysis of relevant policies and their impacts on pharmaceutical excipients industry
Chart 37： Summary of drug safety accidents caused by pharmaceutical excipients
Chart 38： Risk management process of raw and auxiliary materials
Chart 39： Responsibilities and contents of risk management of raw and auxiliary materials
Chart 40： Environmental Protection Executive Standards for pharmaceutical excipients industry
Chart 41：2005-2021 Change in the number of patent applications related to pharmaceutical excipients industry in （ Company ： Pieces of ）
Chart 42：2013-2021 Quality analysis of patent output of pharmaceutical excipients industry in （ Company ： Pieces of ,%）
Chart 43： The composition of patent applicants related to pharmaceutical excipients industry （ Company ：%）
Chart 44： The scale and consumption of the global auxiliary materials market （ Company ： Billion dollars , Ten thousand tons of ,%）
Chart 45： Global excipient compound Market Structure （ By type of compound ）（ Company ：%）
Chart 46： In recent years, the sales and growth of the global auxiliary compound Market （ Company ： Billion dollars , Billion pounds ,%）
Chart 47： International organic pharmaceutical excipients product structure （ Company ：%）
Chart 48： International inorganic pharmaceutical excipients product structure （ Company ：%）
Chart 49： accord with USP The structure of medicinal water （ Company ：%）
Chart 50： The world's major pharmaceutical excipients manufacturers and their major excipients products
Chart 51： The global pharmaceutical excipients consumption market is divided into regions （ Company ：%）
Chart 52： Requirements for declaration of new auxiliary materials in the United States
Chart 53： Biosafety data required for us excipients declaration
Chart 54： Some amendments to the new USP
Chart 55： Relevant requirements of EU on pharmaceutical excipients in drug specifications
Chart 56： The supervision mode of pharmaceutical excipients production in Europe and the United States
Chart 57： Comparison of domestic and foreign auxiliary material management systems
Chart 58： Comparison of definitions of new excipients between domestic and foreign regions
Chart 59： Differences between China and the United States in the types and frequency of use of pharmaceutical excipients
Chart 60： Standard comparison between imported and domestic auxiliary materials
Chart 61： Some new auxiliary materials that have obtained domestic registration certificates
Chart 62： Research and development characteristics of foreign new auxiliary materials
Chart 63： Differences in the application and research of pharmaceutical excipients at home and abroad
Chart 64： Domestic differences in Application Research of new excipients
Chart 65： Rogate's direct tablet pressing excipients
Chart 66： Rogate's investment activities in China
Chart 67：2016-2021 Operation of Dow Chemical Company in （ Company ： Billion dollars ）
Chart 68：2016-2021 BASF's operation in （ Company ： Billions of euros ）
Chart 69：2016-2021 Operation of Degussa in （ Company ： Billions of euros ）
Chart 70： Jiafasai （Gattefossé） Application of micro lotion in pharmaceutical industry
Chart 71： Asahi Kasei Co., Ltd. pharmaceutical excipients product application
Chart 72：2015-2021 Operation of Asahi Kasei Co., Ltd （ Company ： Billion yen ）
Chart 73： Asahi Kasei Co., Ltd. Company and business in China
Chart 74： Hercules' global and regional distribution （ Company ： Million dollars , individual , people ,%）
Chart 75： The development stage of pharmaceutical excipients industry in China
Chart 76： The development characteristics of Chinese pharmaceutical excipients industry
Chart 77： Composition of quality standards for pharmaceutical excipients in China
Chart 78：2014-2021 Statistics on the market scale of Chinese pharmaceutical excipients in （ Company ： One hundred million yuan ）
Chart 79：2014-2021 Market scale and growth trend of Chinese pharmaceutical excipients in （ Company ： One hundred million yuan ,%）
Chart 80： The overall structure of Chinese pharmaceutical excipients industry （ Company ：%）
Chart 81： Composition of manufacturers of oral administration excipients （ Company ：%）
Chart 82： The composition of external auxiliary material production enterprises （ Company ：%）
Chart 83： The composition of the manufacturers of excipients for injection administration is （ Company ：%）
Chart 84： Multinational enterprises have laid out the domestic pharmaceutical excipients market （ Company ：%）
Chart 85： Competition analysis of existing enterprises in pharmaceutical excipients industry
Chart 86： Competition analysis of existing enterprises in pharmaceutical excipients industry
Chart 87： Threat analysis of potential entrants in pharmaceutical excipients industry
Chart 88： Threat analysis of substitutes in pharmaceutical excipients industry
Chart 89： Analysis on the bargaining power of the pharmaceutical excipients industry to the upstream
Chart 90： Downstream bargaining power analysis
Chart 91： Five forces analysis conclusion of pharmaceutical excipients industry
Chart 92： Applicable conditions of cost strategy
Chart 93： The conditions that an enterprise that is suitable for implementing a centralized strategy should have
Chart 94：“ production + sales ” The analysis of business model
Chart 95：“ production + OEM ” The analysis of business model
Chart 96：“ Research and development + manufacturing - sales ” The analysis of business model
Chart 97：“ production + service ” The analysis of business model
Chart 98： Direct selling VS On a commission basis
Chart 99： The emerging marketing model of pharmaceutical excipients industry
Chart 100： Analysis on the advantages and disadvantages of regional brands in China's pharmaceutical excipients industry
Chart 101： Application of modified starch and starch derivatives in pharmaceutical industry
Chart 102： Market size of starch products
Chart 103： Application of medicinal lactose in solid preparations
Chart 104： Pharmacopoeia standard for lactose
Chart 105： The main manufacturers of medicinal lactose in China
Chart 106： Application of medicinal mannitol
Chart 107： Application of medicinal gelatin
Chart 108： In recent years, gelatin production from various sources in the international market （ Company ： Tons of ）
Chart 109： Regional distribution of global gelatin consumption （ Company ：%）
Chart 110： Competition pattern of domestic gelatin Market （ Company ：%）
Chart 111： The output of main natural pigment products in China （ Company ： Tons of ）
Chart 112：2022-2028 China's beet red output and its growth forecast in （ Company ： Tons of ,%）
Chart 113： The export price trend of saccharin sodium in recent years （ Company ： dollar /kg）
Chart 114： The trend of aspartame export price in recent years （ Company ： dollar /kg）
Chart 115： The development stage of medical xylitol industry in China
Chart 116： Market share of medical xylitol production enterprises （ Company ：%）
Chart 117： Different uses and dosage of medicinal sorbitol in pharmaceutical excipients （ Company ：%）
Chart 118：2022-2028 Sales scale and forecast of global pharmaceutical hyaluronic acid in （ Company ： Billion dollars ）
Chart 119： Application of excipients in slow and controlled release preparations